Saturated bicyclic heterocyclic derivatives as SMO antagonists

Inventors: Danila Branca (Rome, IT); Federica Ferrigno (Rome, IT); Jose Ignacio Martin Hernando (Rome, IT); Philip Jones (Brookline, MA); Olaf Kinzel (Rome, IT); Savina Malancona (Rome, IT); Ester Muraglia (Rome, IT); Maria Cecilia Palumbi (Rome, IT); Giovanna Pescatore (Rome, IT); Rita Scarpelli (Rome, IT)

Assignee: Instituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L.

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 8,470,823
App. No.: 13/060,718
Granted: Jun 25, 2013
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

The present invention relates to compounds of formula I: and pharmaceutically acceptable salts or tautomers thereof which are inhibitors of the Sonic Hedgehog pathway, in particular Smoantagonists. Thus the compounds of this invention are useful for the treatment of diseases associated with abnormal hedgehog pathway activation, including cancer, for example basal cell carcinoma, medulloblastoma, prostate, pancreatic, breast, colon, bone and small cell lung cancers, and cancers of the upper GI tract.

Claims (39)

1. A compound of structural formula I:

wherein:

each of m and n is independently 1 or 2;

each of w, y and z is independently 0, 1 or 2;

x is 0 or 1;

A is C 3-7 cycloalkyl or fluoroC 3-7 cycloalkyl;

L is —(X═O) a (NR 7 ) b (O) c (CR 8 R 9 ) d (NR 7 ) e —;

a is 0 or 1;

b is 0 or 1;

c is 0 or 1;

d is 0, 1, 2, 3, 4, 5 or 6;

e is 0 or 1;

R 1 is C 1-6 alkyl, haloC 1-6 alkyl or a ring which is: C 6-10 aryl; C 3-10 cycloalkyl; oxetanyl; azetidinyl; a 5 or 6 membered saturated or partially saturated heterocyclic ring containing one, two or three heteroatoms independently selected from N, O and S; a 5 membered heteroaromatic ring containing 1, 2, 3 or 4 heteroatoms independently selected from N, O and S, not more than one heteroatom of which is O or S; a 6 membered heteroaromatic ring containing one, two or three N atoms; or a 7-15 membered unsaturated, partially saturated or saturated heterocyclic ring containing one, two, three or four heteroatoms independently selected from N, O and S; any of which rings being optionally substituted by one, two or three groups independently selected from R 10 ;

R 2 is a C 1-10 alkyl, haloC 1-10 alkyl, C 1-6 alkylmercaptoC 1-6 alkyl, C 2-10 alkenyl or a ring which is: C 3-10 cycloalkyl; C 6-10 aryl; oxetanyl; azetidinyl; a 5 or 6 membered saturated or partially saturated heterocyclic ring containing one, two or three heteroatoms independently selected from N, O and S; a 5 membered heteroaromatic ring containing 1, 2, 3 or 4 heteroatoms independently selected from N, O and S, not more than one heteroatom of which is O or S; a 6 membered heteroaromatic ring containing one, two or three N atoms; or a 7-15 membered saturated, partially saturated or unsaturated heterocyclic ring containing one, two, three or four heteroatoms independently selected from N, O and S; any of which rings being optionally substituted by one, two, three or four groups independently selected from R 11 ;

each of R 3 , R 4 , R 5 and R 6 is independently C 1-6 alkyl, C 2-10 alkenyl, haloC 1-6 alkyl, hydroxyC 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxyC 1-6 alkyl, carboxy, CO 2 R a , CONR a R b , S(O) n R a or S(O) r NR a R b ;

r is 0, 1 or 2;

R 7 is hydrogen or C 1-6 alkyl;

each of R 8 and R 9 is independently hydrogen, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxycarbonyl or haloC 1-6 alkyl;

each R 10 is independently hydroxy, cyano, halogen, C 1-6 alkyl, haloC 1-6 alkyl, OR a or NR a R b ;

each R 11 is independently hydroxy, oxo, cyano, halogen, C 1-6 alkyl, C 1-6 alkylcarbonyl, C 2-10 alkenyl, C 2-10 alkynyl, haloC 1-6 alkyl, hydroxyC 1-6 alkyl, carboxy, nitro, OR a , NR a R b , NR a COR b , NR a S(O) n R b , NR a S(O) n NR a R b , CO 2 R a , CONR a R b , S(O) n R a , S(O) n NR a R b or a ring which is: C 3-10 cycloalkyl, C 6-10 aryl, C 6-10 aryloxy, C 6-10 arylC 1-6 alkoxy, C 6-10 arylC 1-6 alkyl, azetidinyl, a 5 or 6 membered saturated or partially saturated heterocyclic ring containing one, two or three heteroatoms independently selected from N, O and S, a 5 membered heteroaromatic ring containing 1, 2, 3 or 4 heteroatoms independently selected from N, O and S, not more than one heteroatom of which is O or S or a 6 membered heteroaromatic ring containing one, two or three N atoms; any of which rings being optionally substituted by one, two or three groups independently selected from hydroxy, oxo, cyano, halogen, C 1-6 alkyl, C 1-6 alkylsulfonyl, haloC 1-6 alkyl, C 1-6 alkoxy and haloC 1-6 alkoxy;

X is C or S═O;

each of R a and R b is independently hydrogen, C 1-6 alkyl, C 1-6 alkylcarbonyl, haloC 1-6 alkyl, hydroxyC 1-6 alkyl, C 3-10 cycloalkyl or C 6-10 aryl, any of which rings being optionally substituted by one, two or three groups independently selected from halogen and C 1-6 alkyl;